Medicine and Dentistry
Kidney Function
100%
Chronic Kidney Disease
90%
Sarcopenia
72%
Physical Performance
43%
Glomerular Filtration Rate
39%
Diabetes
36%
Geriatric Assessment
31%
Quality of Life
30%
Community-Dwelling Older Adults
26%
Deterioration
24%
Prevalence
23%
Cohort Analysis
22%
Creatinine
21%
Hand Grip
20%
Comorbidity
19%
Cardiovascular Risk
18%
Cohort Study
18%
Hemodynamic
18%
Arterial Stiffness
18%
Diabetes Mellitus
18%
COVID-19
18%
Health Care Cost
18%
Congestive Heart Failure
18%
Inflammatory Arthritis
18%
Disease Modifying Antirheumatic Drug
18%
Rheumatoid Arthritis
18%
Albumin
14%
Frailty
13%
Infection
13%
Functional Disease
12%
Cognitive Defect
11%
Visual Analog Scale
11%
Prospective Cohort Study
9%
Systolic Blood Pressure
9%
Pulse Wave Velocity
9%
Hospital Mortality
9%
Hand Grip Strength
9%
Decision Making
8%
Biological Marker
7%
Body Mass Index
7%
Outpatient
7%
Hazard Ratio
7%
Odds Ratio
6%
Adverse Event
6%
Cytokine
5%
Multivariate Analysis
5%
Nursing and Health Professions
Chronic Kidney Failure
72%
Frailty
54%
Comorbidity
45%
Cohort Analysis
44%
Estimated Glomerular Filtration Rate
40%
Hospital Mortality
27%
Quality of Life
24%
Deterioration
24%
Geriatric Assessment
23%
Grip Strength
22%
Creatinine
20%
Pandemic
19%
Muscle Mass
18%
Predictive Value
18%
Marital Status
18%
Arterial Stiffness
18%
Confidence Interval
18%
Cardiovascular Risk
18%
Infection
18%
Functional Disease
18%
Health Care Cost
18%
Albumin
18%
Logistic Regression Analysis
14%
Prospective Cohort Study
11%
Systolic Blood Pressure
10%
Hemodynamic Parameter
10%
Pulse Wave
10%
Practice Guideline
10%
Learning Theory
9%
Care of Older People
9%
Hazard Ratio
9%
Diseases
9%
Depressive Disorder
9%
Information Technology
9%
Proportional Hazards Model
6%
Adverse Event
6%
Deprescribing
6%
Disease Severity
6%
Charlson Comorbidity Index
6%
Biological Marker
5%
Pharmacology, Toxicology and Pharmaceutical Science
Frailty
49%
Cohort Study
42%
Chronic Kidney Failure
36%
Comorbidity
26%
Hospital Mortality
24%
Pandemic
19%
Disease Modifying Antirheumatic Drug
18%
Rheumatoid Arthritis
18%
Inflammatory Arthritis
18%
Infection
13%
Diseases
9%
Inflammation
7%
Biological Marker
7%
Prospective Cohort Study
7%
Cytokine
5%